Selective Induction of Cancer Cell Death by Targeted Granzyme B
The potential utility of immunotoxins for cancer therapy has convincingly been demonstrated in clinical studies. Nevertheless, the high immunogenicity of their bacterial toxin domain represents a critical limitation, and has prompted the evaluation of cell-death inducing proteins of human origin as...
Main Authors: | Robert A. Jabulowsky, Pranav Oberoi, Winfried S. Wels |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-02-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4468/2/1/130 |
Similar Items
-
Characterization of a Single Chain Fv Antibody that Reacts with Free Morphine
by: Kazuhisa Sugimura, et al.
Published: (2013-02-01) -
A Cassette Vector System for the Rapid Cloning and Production of Bispecific Tetravalent Antibodies
by: Stefanie Claudia Pohl, et al.
Published: (2012-04-01) -
Production and characterization of a single-chain Fv antibody–alkaline phosphatase fusion protein specific for ampicillin
by: Kuo He, et al.
Published: (2019-01-01) -
Recombinant Antibodies against Mycolactone
by: Leslie Naranjo, et al.
Published: (2019-06-01) -
Targeted Apoptosis Activation with GrB/scFvMEL Modulates Melanoma Growth, Metastatic Spread, Chemosensitivity, and Radiosensitivity
by: Yuying Liu, et al.
Published: (2006-02-01)